GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 70 filers reported holding GLYCOMIMETICS INC in Q2 2017. The put-call ratio across all filers is 3.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,875,000 | +63.0% | 311,013 | +23.9% | 0.35% | +32.1% |
| Q4 2018 | $2,377,000 | -34.2% | 251,013 | 0.0% | 0.27% | -35.4% |
| Q3 2018 | $3,615,000 | -6.6% | 251,013 | +4.6% | 0.42% | -22.3% |
| Q2 2018 | $3,870,000 | +58.9% | 239,933 | +60.0% | 0.53% | +44.3% |
| Q1 2018 | $2,435,000 | -55.4% | 150,000 | -53.8% | 0.37% | -42.2% |
| Q4 2017 | $5,457,000 | +52.4% | 325,000 | +1.3% | 0.64% | +5.3% |
| Q2 2017 | $3,580,000 | -15.0% | 320,796 | -58.6% | 0.61% | -26.2% |
| Q1 2017 | $4,213,000 | -7.4% | 775,796 | +4.0% | 0.82% | -28.4% |
| Q4 2016 | $4,549,000 | -11.4% | 745,796 | +3.9% | 1.15% | +37.7% |
| Q3 2016 | $5,134,000 | -1.6% | 718,080 | 0.0% | 0.84% | -38.3% |
| Q2 2016 | $5,220,000 | +159.2% | 718,080 | +112.5% | 1.36% | +210.1% |
| Q1 2016 | $2,014,000 | +16.3% | 337,911 | +218.8% | 0.44% | +10.6% |
| Q1 2014 | $1,731,000 | – | 106,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,000,000 | $5,220,000 | 0.73% |
| NEA Management Company, LLC | 4,764,440 | $8,290,126 | 0.63% |
| Artal Group S.A. | 8,589,064 | $14,945 | 0.46% |
| BVF INC/IL | 9,544,262 | $16,607,016 | 0.46% |
| Sargent Investment Group, LLC | 108,000 | $187,920 | 0.05% |
| Intellectus Partners, LLC | 73,475 | $127,847 | 0.04% |
| XTX Topco Ltd | 29,998 | $52,197 | 0.01% |
| AXA S.A. | 1,631,509 | $2,838,826 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,149,656 | $1,999 | 0.01% |
| TOBIAS FINANCIAL ADVISORS, INC. | 15,000 | $26,100 | 0.01% |